1.16
Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | 0.022 |
|
7.77%
65.19
|
60.49 | 71.77 | 71.43 | 69.53 |
Operating Income/Loss |
7.77%
-65.19
|
-60.49 | -71.77 | -71.43 | -69.50 |
Nonoperating Income/Loss |
449.09%
5.458
|
0.994 | 5.481 | 5.073 | 4.504 |
Income/Loss From Equity Method Investments |
-
|
- | -1.134 | 0.375 | -0.929 |
Income/Loss From Continuing Operations Before Tax |
0.40%
-59.73
|
-59.50 | -66.29 | -66.36 | -65.00 |
Income/Loss From Continuing Operations After Tax |
0.34%
-59.73
|
-59.94 | -66.29 | -66.36 | -65.00 |
|
0.34%
-59.73
|
-59.94 | -66.29 | -66.36 | -65.00 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,970%
215.36
|
5.2919 | 209.19 | 190.03 | 169.13 |
Diluted Average Shares |
3,970%
215.36
|
5.2919 | 209.19 | 190.03 | 169.13 |
Basic Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.32 | -0.35 | -0.38 |
Diluted Earnings Per Share |
0.00%
-0.28
|
-0.28 | -0.32 | -0.35 | -0.38 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):